Literature DB >> 25966488

Automating risk of bias assessment for clinical trials.

Iain J Marshall, Joël Kuiper, Byron C Wallace.   

Abstract

Systematic reviews, which summarize the entirety of the evidence pertaining to a specific clinical question, have become critical for evidence-based decision making in healthcare. But such reviews have become increasingly onerous to produce due to the exponentially expanding biomedical literature base. This study proposes a step toward mitigating this problem by automating risk of bias assessment in systematic reviews, in which reviewers determine whether study results may be affected by biases (e.g., poor randomization or blinding). Conducting risk of bias assessment is an important but onerous task. We thus describe a machine learning approach to automate this assessment, using the standard Cochrane Risk of Bias Tool which assesses seven common types of bias. Training such a system would typically require a large labeled corpus, which would be prohibitively expensive to collect here. Instead, we use distant supervision, using data from the Cochrane Database of Systematic Reviews (a large repository of systematic reviews), to pseudoannotate a corpus of 2200 clinical trial reports in PDF format. We then develop a joint model which, using the full text of a clinical trial report as input, predicts the risks of bias while simultaneously extracting the text fragments supporting these assessments. This study represents a step toward automating or semiautomating extraction of data necessary for the synthesis of clinical trials.

Mesh:

Year:  2015        PMID: 25966488     DOI: 10.1109/JBHI.2015.2431314

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   5.772


  5 in total

1.  Rationale-Augmented Convolutional Neural Networks for Text Classification.

Authors:  Ye Zhang; Iain Marshall; Byron C Wallace
Journal:  Proc Conf Empir Methods Nat Lang Process       Date:  2016-11

2.  Is it time for computable evidence synthesis?

Authors:  Adam G Dunn; Florence T Bourgeois
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

3.  Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor.

Authors:  Perrine Créquit; Ludovic Trinquart; Philippe Ravaud
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

4.  Improving reference prioritisation with PICO recognition.

Authors:  Austin J Brockmeier; Meizhi Ju; Piotr Przybyła; Sophia Ananiadou
Journal:  BMC Med Inform Decis Mak       Date:  2019-12-05       Impact factor: 2.796

5.  Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer.

Authors:  Perrine Créquit; Ludovic Trinquart; Amélie Yavchitz; Philippe Ravaud
Journal:  BMC Med       Date:  2016-01-20       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.